May – Welcome from the Medical and Research Director

Prof. J. William McEvoy

NIPC Medical and Research Director, Chair of Executive Council

Dear Alliance Members,

Welcome to our NIPC eBulletin for May 2023. As the academic year draws to a close, you may be thinking about further or new education opportunities. I highly encourage you to consider applying for our unique range of Masters progammes being run in partnership with the University of Galway.

hese courses focus on the prevention and control of heart disease, stroke, diabetes, obesity and enabling active lifestyles, health and well-being. This portfolio of preventive programmes is unique in the world and a qualification in this area will leave you well placed to respond to the most pressing areas in preventive medicine. The dates have also been announced for the 2023 NIPC conferences and I urge you to add those dates to your diaries. NIPC continue to deliver high quality courses all year round and new courses have just been added to the calendar, more on those below.

On the research front we are hoping to present the results of our international survey (INTERASPIRE) at the European Society of Cardiology scientific conference in August and preparing the results to this end. I am also delighted that our collaboration with Johns Hopkins on the study of high-sensitivity troponin in the American NHANES study is finally bearing fruit, with 2 major papers just released that have the potential to redefine the approach to the diagnosis of heart attack and heart injury.

• Myocardial Injury Thresholds for 4 High-Sensitivity Troponin Assays in a Population-Based Sample of US Children and Adolescents
• Myocardial Injury Thresholds for 4 High-Sensitivity Troponin Assays in U.S Adults

Also, if you have not already done so, I encourage you to consider reviewing the results of our MySlainte virtual cardiac rehab study in Ireland, which are now published open access HERE.

Many thanks,
-Bill